Glycaemic control in people with type 2 diabetes mellitus during and after cancer treatment: A systematic review and meta-analysis.

ABSTRACT:

Background

Cancer and Diabetes Mellitus (DM) are leading causes of death worldwide and the prevalence of both is escalating. People with co-morbid cancer and DM have increased morbidity and premature mortality compared with cancer patients with no DM. The reasons for this are likely to be multifaceted but will include the impact of hypo/hyperglycaemia and diabetes therapies on cancer treatment and disease progression. A useful step toward addressing this disparity in treatment outcomes is to establish the impact of cancer treatment on diabetes control.

Aim

The aim of this review is to identify and analyse current evidence reporting glycaemic control (HbA1c) during and after cancer treatment.

Methods

Systematic searches of published quantitative research relating to co

SUBMITTER: Pettit S 

PROVIDER: S-EPMC5415164 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature